Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T00:33:28.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page and updated the page revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T22:45:56.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page adds UI/metadata elements (Show glossary; Results First Posted and Last Update Posted timestamps; Revision: v3.4.0) and removes older labels (Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-27T21:19:42.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    The page now includes a consolidated Locations section listing Florida, Massachusetts, and New York sites, replacing the previous separate location pages for these sites.
    Difference
    0.4%
    Check dated 2025-12-22T22:38:02.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    A new citation is added in Publications: Snyder et al., 2014 NEJM on CTLA-4 blockade in melanoma. The Erratum reference for that paper is removed.
    Difference
    0.1%
    Check dated 2025-12-15T20:59:20.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.3.1 removed; this is a minor site maintenance update and does not alter study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T12:48:52.000Z thumbnail image

Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.